Thank you, Rajiv. Before I discuss our financial result and outlook, I would like to first provide a summary of the Audit Committee's completed review of our third-party software usage and the resulting implications. Upon completion of the investigation, the Audit Committee found that evaluation software from two of our third-party providers was used in a non-compliant manner for interoperability testing, validation, customer proof-of-concept, training and customer support over a multi-year period. In addition, the Audit Committee concluded that certain employees engaged in intentional misconduct to conceal use of evaluation software with respect to one of our third-party providers in violation of our code of business conduct and ethics and other policies. We have terminated employment for certain employees who were found to be primarily responsible for the intentional misconduct. Through the investigation, we identified a material weakness in our internal control over financial reporting. In particular, we determined that our controls did not effectively provide the information and communication necessary to identify non-compliant use of third-party software. To address this material weakness, we are implementing or will implement several remedial measures, including enhanced internal processes, enhanced training and continued communication regarding the importance of integrity and raising concerns in a timely manner. We have accounted for the estimated financial impact of this issue by recording cumulative estimated expenses of $11 million as of Q2 2023, which represents the estimable amount of future payments for past non-compliant usage of software from these two vendors accrued over a multi-year period. We have accordingly also corrected the prior period financials shown in the 10-Q filed earlier today. We expect the incremental ongoing annual impact to operating expenses of this third-party software usage to be approximately in the low single-digit millions of dollars. You can find additional information, including our complete Q2 2023 results and information about the estimated financial impact and remedial measures related to the third-party software review in our 10-Q quarterly report for Q2 2023 that we filed earlier today with the SEC. We are pleased that this investigation has been completed. I will now provide commentary on our Q3 2023 results, followed by the outlook for Q4 2023 and the full-year 2023. Q3 was a good quarter during which we beat all guided metrics. ACV billings in Q3 was $240 million higher than our guidance of $220 million to $225 million, and representing a year-over-year growth of 17%. Revenue in Q3 was $449 million higher than our guidance of $430 million to $440 million and a year-over-year growth of 11%. ARR at the end of Q3 was $1.467 billion, a year-over-year growth of 32%. New logo additions were about 430 in Q3. Average contract duration in Q3 was three years flat quarter-over-quarter as expected. As described previously, the percentage of orders with future start dates likely due to partner supply chain constraints continue to be an assumption in our Q3 guidance. Q3 revenue benefited approximately $5 million from the reduction in percentage of future start dates over time as more license revenue was recognized in quarter than deferred in line with the $5 million estimate we had provided on our last earnings call. As supply chain challenges faced by our server partners appear to have normalized, we expect its impact on our business to normalize as well. As a result, going forward, we will not continue to provide this quantification of revenue impact from orders with future start dates. Non-GAAP gross margin in Q3 was 84%. Non-GAAP operating expenses in Q3 were $369 million. Non-GAAP operating margin in Q3 was 2%, including the impact of about $10 million in non-recurring tax obligations related to a portion of our employee RSUs that vested in Q3 and approximately $9 million of non-recurring legal and advisory expenses, both of which related to the third-party software review and the delay in our 10-Q filing for Q2. Excluding these one-time items, non-GAAP operating margin in Q3 would have been approximately 6%. Non-GAAP net income in Q3 was $12 million or EPS of $0.04 per share based on fully diluted weighted average shares outstanding of approximately 282 million shares. Billings linearity was good and DSOs were 28 days in Q3. Free cash flow in Q3 was $42 million, implying free cash flow margin of 9%. A few additional notes on Q3 free cash flow. One, the approximately $31 million payment for the settlement of the previously outstanding securities class action litigation, which is the amount inclusive of legal fees and expenses and net of our expected recovery under our D&O insurance is now expected to be paid and settled in Q4 rather than in Q3 as previously expected. The change in timing is due to routine process. Two, the $42 million of free cash flow in Q3 includes the impact of approximately $10 million of cash usage in Q3 for non-recurring tax obligations related to a portion of our employee RSUs that vested in March as expected and mentioned on our last earnings call and caused by the delay in our Q2 10-Q filing. Three, the delay in our Q2 10-Q filing also meant that we paused our ESPP program, delaying an estimated $20 million of net cash outflow related to ESPP, which would normally occur in Q3 to Q4. And four, free cash flow in Q3 was also impacted by approximately $6 million of payments for non-recurring legal and advisory expenses related to the third-party software review. We ended Q3 with cash, cash equivalents and short-term investments of $1.358 billion, up slightly from $1.311 billion in Q2 2023. Moving on to Q4. The guidance for Q4 fiscal 2023 is as follows: ACV billings of $240 million to $250 million, revenue of $470 million to $480 million, non-GAAP gross margin of approximately 84% and non-GAAP operating margin of 9% to 10%. Moving on to the full-year outlook with one quarter left. The guidance for fiscal year 2023 is as follows: ACV billings of $915 million to $925 million, a year-over-year growth of 22% at the midpoint of the range; revenue of $1.84 billion to $1.85 billion, a year-over-year growth of 17% at the midpoint; non-GAAP gross margin of approximately 84%; non-GAAP operating margin of 6% to 7%, a year-over-year improvement of over 10 points of margin at the midpoint; free cash flow of $125 million to $135 million, implying a free cash flow margin of 7% at the midpoint. I will now provide some color on our full-year guidance. First, we are seeing continued new and expansion opportunities for our solutions despite the uncertain macro environment. However, as Rajiv mentioned, and similar to last quarter, we have seen a modest elongation of sales cycles likely due to increased deal inspection. Our fiscal year 2023 new and expansion ACV performance remains impacted by some of these macro dynamics and is performing slightly below our expectations entering the year and what we believe is longer term potential is. We have considered this dynamic in our updated guidance. The renewal business continues to perform well. However, it tends to be at a lower aggregate average contract duration compared to our new and expansion business. Our relative economics on renewals have also continued to improve over time as the renewals team has improved their execution. Second, similar to our comments last quarter, the full-year guidance assumes that contract duration would decrease slightly compared to fiscal year 2022. Third, as stated previously, non-GAAP operating margin outlook for fiscal year 2023 is 6% to 7%. Excluding the one-time expenses related to the third-party software review, this range would have been 7% to 8%. Finally, the updated free cash flow guidance of $125 million to $135 million includes the impact of the following non-recurring items totaling about $65 million. Approximately $10 million of cash usage in Q3 for non-recurring tax obligations related to a portion of our employee RSUs vesting, which is non-recurring because it was due to the delayed filing of our 10-Q. Approximately $31 million in net cash outflow expected in Q4 from the previously mentioned litigation settlement. Approximately $15 million for legal and advisory fees related to the third-party software review across Q3 and Q4. And finally, an $11 million estimated payment in Q4 for the potential resolution with the third-party software vendors. In closing, we are pleased that our Q3 results reflect our continued execution towards our stated objective of sustainable, profitable growth, and we expect to continue that focus. With that, operator, please open the line for questions.